Our Services
Medical Information
Helpful Resources
Published on: 9/23/2026
Flu vaccine effectiveness shifts every season, generally cutting the risk of getting sick by roughly 40% to 60% when the vaccine matches the strains that are actually circulating, and less when there is a mismatch or mid-season drift. Even in lower-match years, vaccination still meaningfully reduces the chance of severe illness, hospitalization, and death, though protection varies by age, underlying conditions, and which influenza type is dominant. There are several important factors that determine how well it works for you personally, so see below to understand more before drawing conclusions from the headline numbers alone. If you are already feeling feverish, achy, congested, or run down, guessing whether it is flu, a cold, COVID-19, or something else wastes time you could spend on treatment that works best in the first 48 hours. Take a free, instant, online symptom check to see which conditions best explain what you are experiencing and get clear guidance on whether to rest at home, call your doctor, or seek urgent care.
Last reviewed for medical accuracy: 09/23/2026
Every fall, millions of people ask: is the flu shot effective this year? While flu vaccine effectiveness can vary, health experts agree it remains the best tool to reduce your risk of serious illness, hospitalization and even death from influenza.
Based on reports from public health agencies and recent studies:
These numbers mean that if 100 unvaccinated people get the flu, about 40–60 vaccinated people might still avoid it. Effectiveness can shift as the season progresses and different flu strains circulate.
A vaccine that’s 50% effective doesn’t sound ideal, but it still delivers big benefits:
Think of it this way: halving your risk of flu can translate into thousands fewer hospital stays nationwide and countless lives saved.
Q: I’ve had the shot before and still got sick. Is it worth it?
A: Yes. No vaccine offers 100% protection, but even in “breakthrough” cases, symptoms are often milder and shorter.
Q: Does the flu shot protect against other respiratory viruses?
A: No. It’s tailored to influenza A and B. You still need to practice good hand hygiene and consider other vaccines (like COVID-19 boosters) where recommended.
Q: How soon does protection start, and how long does it last?
A: Immunity kicks in about two weeks after your shot and generally lasts through the main flu season (about six months).
Flu vaccines go through rigorous testing before approval. Common side effects are mild:
The risk of serious side effects is extremely low compared to complications from a severe flu infection.
Combining vaccination with everyday precautions helps you stay well:
If you start to feel flu-like symptoms, you may want a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps.
The Centers for Disease Control and Prevention (CDC) recommends annual flu shots for everyone aged six months and older. Special emphasis for:
If you experience:
…you should speak to a doctor immediately. For urgent or life-threatening concerns, call emergency services.
Staying informed and proactive helps you make the best choices for your health. While yearly effectiveness can shift, the flu vaccine consistently reduces your chance of serious illness. Talk to your healthcare provider about getting vaccinated, and use trusted tools—like the Ubie Symptom Checker—to manage your health with confidence.
(References)
* Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S. A brief review of influenza virus infection. J Med Virol. 2021 Aug;93(8):4638-4646. doi: 10.1002/jmv.26990. Epub 2021 Apr 14. PMID: 33792930.
* Uyeki TM. Influenza. Ann Intern Med. 2021 Nov;174(11):ITC161-ITC176. doi: 10.7326/AITC202111160. Epub 2021 Nov 9. PMID: 34748378.
* Cowling BJ, Okoli GN. Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine. Drugs. 2024 Sep;84(9):1013-1023. doi: 10.1007/s40265-024-02083-8. Epub 2024 Aug 21. PMID: 39167316; PMCID: PMC11438668.
* Taaffe J, Ostrowsky JT, Mott J, Goldin S, Friede M, Gsell P, Chadwick C. Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact. Vaccine. 2024 Dec 2;42(26):126408. doi: 10.1016/j.vaccine.2024.126408. Epub 2024 Oct 5. PMID: 39369576; PMCID: PMC11672241.
* Presa J, Arranz-Herrero J, Alvarez-Losa L, Rius-Rocabert S, Pozuelo MJ, Lalueza A, Ochando J, Eiros JM, Sanz-Muñoz I, Nistal-Villan E. Influenza vaccine outcomes: a meta-analysis revealing morbidity benefits amid low infection prevention. Eur Respir Rev. 2025 Jan;34(175). doi: 10.1183/16000617.0144-2024. Epub 2025 Jan 8. PMID: 39778922; PMCID: PMC11707602.
* Pardo-Seco J, Rodríguez-Tenreiro-Sánchez C, Giné-Vázquez I, Mallah N, Mirás-Carballal S, Piñeiro-Sotelo M, Cribeiro-González M, Conde-Pájaro M, González-Pérez JM, Rivero-Calle I, Bello X, Razzini JL, Dacosta-Urbieta A, Salas A, Harris RC, Loiacono MM, van Aalst R, Farré JM, Dufournet M, Johansen ND, Modin D, Biering-Sørensen T, Durán-Parrondo C, Martinón-Torres F, GALFLU Trial Team. High-Dose Influenza Vaccine to Reduce Hospitalizations. N Engl J Med. 2025 Dec 11;393(23):2303-2312. doi: 10.1056/NEJMoa2509834. Epub 2025 Aug 30. PMID: 40888694.
* Johansen ND, Modin D, Loiacono MM, Harris RC, Dufournet M, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Bartholdy KV, Bernholm KF, Borchsenius JIH, Davidovski FS, Davodian LW, Dons M, Duus LS, Espersen C, Fussing FH, Jensen AMR, Landler NE, Langhoff ACF, Lassen MCH, Nielsen AB, Ottosen CI, Sengeløv M, Skaarup KG, Solomon SD, Landray MJ, Gislason GH, Køber L, Ralfkiaer L, Nealon J, Sivapalan P, Martel CJ, Jensen JUS, Biering-Sørensen T. High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults. N Engl J Med. 2025 Dec 11;393(23):2291-2302. doi: 10.1056/NEJMoa2509907. Epub 2025 Aug 30. PMID: 40888720.
* Scott J, Abers MS, Marwah HK, McCann NC, Meyerowitz EA, Richterman A, Fleming DF, Holmes EJ, Moat LE, Redepenning SG, Smith EA, Stoddart CJ, Sundaram ME, Ulrich AK, Alba C, Anderson CJ, Arpey MK, Borre E, Ladines-Lim J, Mehr AJ, Rich K, Watts C, Basta NE, Jarolimova J, Walensky RP, Dugdale CM. Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026. N Engl J Med. 2025 Dec 4;393(22):2221-2242. doi: 10.1056/NEJMsa2514268. Epub 2025 Oct 29. PMID: 41160817.
* Fitz-Patrick D, McVinnie DS, Jackson LA, Crowther G, Geevarughese A, Cannon KD, Garcia LM, Pineiro Puebla Y, Yi Z, Cunliffe L, Maniar A, Zareba AM, Ianos CA, Gomme E, Koury K, Suphaphiphat Allen P, Anderson AS, Gurtman A, Lindert K, Pfizer C4781004 Trial Investigators. Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine. N Engl J Med. 2025 Nov 20;393(20):2001-2011. doi: 10.1056/NEJMoa2416779. PMID: 41259756.
* Kirsebom FC, Thompson C, Talts T, Kele B, Whitaker HJ, Andrews N, Abdul Aziz N, Rawlinson C, Green RE, Quinot C, Gardner N, Waller E, Allen A, Watson CH, McDonald SL, Zambon M, Pebody R, Ramsay M, Hoschler K, Singanayagam A, Lopez Bernal J. Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K. Euro Surveill. 2025 Nov;30(46). doi: 10.2807/1560-7917.ES.2025.30.46.2500854. PMID: 41267661; PMCID: PMC12639273.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.